Neurology Diagnostics’ Role in Advancing Alzheimer’s Research: LUCIDITY Phase 3 Outcomes

joel.desrochers • October 16, 2023

Share this article

We are pleased to announce advancements in Alzheimer’s Disease research, stemming from the Phase 3 LUCIDITY trial. Neurology Diagnostics has had the privilege of participating in this trial, and are thrilled to share the compelling results, recently released.

The LUCIDITY Phase 3 trial has brought to light exciting new evidence. Participants receiving the investigational product, ‘HMTM’ experienced a significant reduction in neurofilament light chain blood concentrations (NfL). NfL levels have been closely correlated with the destruction of neurons in the brain. Therefore, lower levels of this protein are a promising sign, showing dramatically slowed progression of Alzheimer's Disease. Additionally, this reduction was closely linked to improvements in memory and other cognitive tests.

The preliminary outcomes of the LUCIDITY trial are highly promising and pave the way for innovative Alzheimer's research. We wish to express our profound appreciation to our collaborating partners, leading experts, and dedicated participants who have contributed to the success of this groundbreaking work.

Expert Commentary

"This is the first tau aggregation inhibitor to reach the phase 3 stage of development and to produce results like this," noted Dr. Claude Wischik, executive chairman of TauRx Therapeutics, the company behind the new drug. According to Dr. Wischik, the decline in NfL levels suggests a "direct impact on disease pathology."

Upcoming Studies and Recruitment

Our research endeavors continue to expand beyond the compelling findings of the LUCIDITY Phase 3 trial. We are currently planning studies that will delve into Alzheimer’s, Chronic Traumatic Encephalopathies (CTEs), and Parkinson’s disease.

We’re Actively Recruiting: If you know someone impacted by Mild Cognitive Impairment (MCI), Alzheimer's Disease, Multiple Sclerosis (MS) as well as healthy control participants, we invite you to refer them to Neurology Diagnostics.

Recent Posts

By joel.desrochers • July 10, 2025
Managing multiple sclerosis demands a comprehensive approach that includes physical therapy alongside traditional medications. With targeted exercises and stretches, you can protect your strength and mobility.
By joel.desrochers • July 2, 2025
Our dedicated team at NDx Clinical Research recently traveled to attend an exclusive investigator meeting for an exciting new clinical trial evaluating a new biosimilar Botox compound as a potential treatment for chronic migraines!
By joel.desrochers • June 3, 2025
Wondering if a clinical trial might be right for you? These research studies can open doors to new treatments but come with tradeoffs worth considering.
By joel.desrochers • May 2, 2025
Having a tremor can be alarming, but it doesn’t automatically mean you have Parkinson’s disease. Understanding the different causes of tremors and how they differ is essential to getting the treatment you need.
By joel.desrochers • April 11, 2025
FAA medical exams can make or break your flying career. Our guide walks you through what examiners check, which documents to bring, and simple pre-exam adjustments that prevent certification problems. 
By joel.desrochers • March 10, 2025
Could your diet be triggering your migraines? Certain foods, from aged cheese to red wine, might be the culprit behind those debilitating headaches. Learn which common foods to watch for and how to identify your personal triggers.
By joel.desrochers • February 18, 2025
Unexplained numbness, tingling, or muscle weakness could be signs of a nerve or muscle disorder. Electrodiagnostic medicine helps pinpoint the cause so you can get the answers you need to develop the proper treatment.
By joel.desrochers • January 27, 2025
Curious about clinical trials but not sure if they’re right for you? They’re critical for advancing medical treatments, but many people don’t realize how they can benefit from participating. Learn more about how they work and why they matter.
By joel.desrochers • December 9, 2024
Worried about your memory? Get a free cognitive assessment! Learn what to expect during the 15-minute evaluation and discover potential next steps like consulting with a neurologist or participating in clinical trials. Schedule a free cognitive testing NOW
By joel.desrochers • December 3, 2024
Dementia affects millions, altering memory, thinking, and daily life. Here we explore the basics of dementia, from signs and diagnosis to managing care with empathy. Explore expert tips to support your loved one, and yourself, on this journey.
Show More